Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adagio Medical HoldingsADGM +4.06%10 Debt-to-Equity is -62.65 as of Jun. 2026. GuruFocus rates ADGM with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 699 Medical Devices & Instruments companies, Adagio Medical Holdings ranks worse than 143061.37% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Adagio Medical Holdings's Debt-to-Equity or its related term are showing as below:
ADGM'
s Debt-to-Equity Range Over the Past 10 Years
Min: -62.65 Med: 0.04 Max: 4.21
Current: -62.65
During the past 5 years, the highest Debt-to-Equity Ratio of Adagio Medical Holdings was 4.21. The lowest was -62.65. And the median was 0.04.
ADGM's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.24
vs ADGM: -62.65
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Adagio Medical Holdings Debt-to-Equity Related Terms
Adagio Medical Holdings Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADGM vs ALRTF, IRIX, SINT: Debt-to-Equity Comparison
For the Medical Devices subindustry, Adagio Medical Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adagio Medical Holdings Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Adagio Medical Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adagio Medical Holdings (ADGM) has a Debt-to-Equity of -62.65 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adagio Medical Holdings and its competitors. According to the industry distribution chart, Adagio Medical Holdings ranks #999999 out of 699 companies in the Medical Devices & Instruments industry.
Is Adagio Medical Holdings' Debt-to-Equity too high?
Adagio Medical Holdings' current Debt-to-Equity is -62.65. Based on the distribution chart, Adagio Medical Holdings ranks #999999 out of 699 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adagio Medical Holdings has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Adagio Medical Holdings' Debt-to-Equity compare to ALRTF and IRIX?
According to the Medical Devices & Instruments industry distribution chart, Adagio Medical Holdings ranks #999999 out of 699 companies for Debt-to-Equity. This places Adagio Medical Holdings in the lower half of its industry. The industry median Debt-to-Equity is 0.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adagio Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adagio Medical Holdings's current Debt-to-Equity is -62.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adagio Medical Holdings stock overvalued right now?
Adagio Medical Holdings (ADGM) has a current Debt-to-Equity of -62.65. The current Debt-to-Equity is -62.65. Adagio Medical Holdings' overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Adagio Medical Holdings (ADGM), the current Debt-to-Equity is -62.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
10GF Score
Get the complete analysis for ADGM
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADGM has been successfully added to your 
